An analysis of more than 10,000 gliomas and clinical outcomes reported in Nature by scientists in Boston and Paris found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.
- Parasite infestations revealed by tiny chicken backpacks
- Racial disparities in COVID-19 are clear; better data, more targeted action needed
- Study links attraction to ‘tyrannical’ leaders to dysfunctional family dynamics
- Scientists demonstrate a new experiment in the search for theorized ‘neutrinoless’ proc
- 1 in 3 young adults may face severe COVID-19, UCSF study shows